. Author manuscript; available in PMC: 2009 Sep 1.

Published in final edited form as: Mol Cancer Ther. 2008 Sep 2;7(9):3071–3080. doi: 10.1158/1535-7163.MCT-08-0402

Table 2.

Summary of pancreatic tumor TMA immunostaining results for four targets

Target	Sample Classification	Score					% of Cases With ≥ 2+
Target	Sample Classification	0	1+	2+	3+	N/E	% of Cases With ≥ 2+
PTPRR	Normal	2	2	0	0	0	0
	Adjacent Normal	7	21	3	0	7	10
	Tumor	0	12	28	8	4	75
PCDHB10	Normal	3	1	0	0	0	0
	Adjacent Normal	7	27	1	0	3	3
	Tumor	1	21	22	4	4	37
IL1RAP	Normal	4	0	0	0	0	0
	Adjacent Normal	24	5	0	0	9	0
	Tumor	6	19	18	5	4	48
SLC2A13	Normal	2	0	0	0	2	0
	Adjacent Normal	20	10	1	0	7	3
	Tumor	7	18	18	4	5	47